InspireMD Q3 2026 Results: Net Loss of $9.76M, Loss Narrows
InspireMD reported a net loss of $37.8 million for the nine months ended September 30, 2026, compared to $37.0 million in the prior year period. While revenues grew to $7.4 million from $5.8 million year-over-year, the company experienced a significant decrease in cash and marketable securities, ending the period with $19.2 million in cash.
- Key figure
- Net loss $9.76M